Scarica l'app Stockscreener
219.68
2.52%
-5.69
Dopo l'orario di chiusura:
219.60
-0.08
-0.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABBV Giù?
Forum
Previsione
Storia dei dividendi
Abbvie Inc Borsa (ABBV) Ultime notizie
Bimzelx Trial Win Raises New Questions For AbbVie Skyrizi Outlook - simplywall.st
AbbVie (ABBV) Receives a Buy from Berenberg Bank - The Globe and Mail
AbbVie Inc. stock underperforms Friday when compared to competitors - MarketWatch
Is AbbVie Inc. (ABBV) one of the debt free halal stocks to buy? - MSN
Is AbbVie Inc. (ABBV) One of the Debt Free Halal Stocks to Buy? - Insider Monkey
Concorde Financial Exits Howard Hughes Holdings, Developer of Large Sun Belt Communities - The Motley Fool
AbbVie Inc Stock (ISIN: US00287Y1091) Faces Pressure Amid Valuation Concerns and Dividend Appeal - AD HOC NEWS
Revenue per share of AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1 – BCBA:ABBV - TradingView
AbbVie CEO’s pay jumped 75% to $32.5M in second year at the helm - Crain's Chicago
AbbVie Stock: Is This Pharma Giant Still a Buy-or-Bail in 2026? - AD HOC NEWS
AbbVie Inc. $ABBV Shares Sold by Van ECK Associates Corp - MarketBeat
Douglass Winthrop Advisors LLC Buys 9,022 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Holdings Cut by Bokf Na - MarketBeat
RBC Capital Says AbbVie Inc. (ABBV) Growth Story Is Still in Early Stages - Insider Monkey
Antiviral Drugs Market Is Going to Boom Rapidly| AbbVie Inc., GSK plc, and Dr. Reddy's Laboratories Ltd. - openPR.com
AbbVie Reports Promising Results from Phase 1 Study of ABBV-295 - Insider Monkey
How The Narrative For AbbVie (ABBV) Is Shifting On Immunology Growth And Competition Risks - Yahoo Finance
AbbVie’s ABBV-295 Obesity Data Sparks Fresh Interest In Valuation - simplywall.st
UCB's Bimzelx Outperforms AbbVie's Skyrizi in Psoriatic Arthritis Trial - GuruFocus
AbbVie’s Skyrizi beaten by UCB’s Bimzelx in psoriatic arthritis - Seeking Alpha
SageView Advisory Group LLC Buys 13,883 Shares of AbbVie Inc. $ABBV - MarketBeat
Kepler Cheuvreux Suisse SA Takes $7.54 Million Position in AbbVie Inc. $ABBV - MarketBeat
Mackenzie Financial Corp Sells 99,604 Shares of AbbVie Inc. $ABBV - MarketBeat
Scotiabank Reaffirms Their Buy Rating on AbbVie (ABBV) - The Globe and Mail
Franklin Resources Inc. Trims Holdings in AbbVie Inc. $ABBV - MarketBeat
Capital World Investors Sells 139,297 Shares of AbbVie Inc. $ABBV - MarketBeat
ABBV Stock Price and Chart — NYSE:ABBV - TradingView
AbbVie Inc. (ABBV) gets downgraded to peer perform from outperform by Wolfe Research - MSN
AbbVie Obesity Drug ABBV-295 Hits Up to 9.8% Weight Loss in Early Trial - TechStock²
AbbVie Forecasts High Single-Digit Growth Through 2030 - National Today
AbbVie’s GLP-1 challenger posts strong weight-loss results in early trial - Crain's Chicago
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Delcath Systems (DCTH) - The Globe and Mail
AbbVie Posts Encouraging Early-Stage Data For Amylin Analog ABBV-295 - Citeline News & Insights
Richard Bernstein Advisors LLC Lowers Holdings in AbbVie Inc. $ABBV - MarketBeat
Capital Research Global Investors Sells 34,749 Shares of AbbVie Inc. $ABBV - MarketBeat
Capital International Investors Has $2.48 Billion Stake in AbbVie Inc. $ABBV - MarketBeat
Capital International Inc. CA Has $55.65 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Legal & General Group Plc Has $2.78 Billion Holdings in AbbVie Inc. $ABBV - MarketBeat
Bank of Montreal Can Raises Stock Position in AbbVie Inc. $ABBV - MarketBeat
William Blair and BMO Maintain Outperform on AbbVie Inc. (ABBV) March 2026 - Meyka
AbbVie reports ‘positive’ results from Phase 1 study of ABBV-295 - TipRanks
AbbVie says CEO Robert Michael's 2025 total compensation was $32.5 millionSEC filing - marketscreener.com
AbbVie (NYSE:ABBV) Shares Down 1% Following Insider Selling - MarketBeat
ICER to review AbbVie’s Parkinson’s disease drug - The Pharma Letter
AbbVie (ABBV) Reports Promising Phase 1 Results for Obesity Trea - GuruFocus
AbbVie's Early Obesity Drug Data Shows Up To 10% Weight Loss - Benzinga
AbbVie sees promising early-stage data for weight loss asset ABBV-295 - Seeking Alpha
AbbVie Trial Updates Add Context To Valuation And Growth Outlook - Yahoo Finance
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Sienna Gestion Boosts Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie (ABBV) Reports Promising Results from Phase 1 Study of AB - GuruFocus
Gubra's partner AbbVie reports positive phase 1 results for ABBV-295 - marketscreener.com
AbbVie reports Positive Phase 1 Multiple Ascending Dose Results for ABBV-295, a Long-Acting Amylin Analog - TradingView
AbbVie Inc. $ABBV Shares Purchased by Schroder Investment Management Group - MarketBeat
Swiss National Bank Trims Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults - Yahoo Finance
AbbVie Inc. $ABBV Shares Acquired by LGT Group Foundation - MarketBeat
Russell Investments Group Ltd. Increases Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Jefferies Financial Group Inc. Sells 53,123 Shares of AbbVie Inc. $ABBV - MarketBeat
Streptococcus Market Is Going to Boom | AbbVie • Pfizer • Merck & Co. • GlaxoSmithKline - openPR.com
AbbVie Inc. (ABBV) Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI Subcutaneous Induction in Patients with Crohn’s Disease - Insider Monkey
First Trust Advisors LP Sells 1,007,670 Shares of AbbVie Inc. $ABBV - MarketBeat
Global drugmakers rush to boost US presence as tariff threat looms - Reuters
AbbVie Inc. (ABBV) is Drawing Interest from Investors: Key Information You Need to Know - Bitget
Vinva Investment Management Ltd Acquires 31,451 Shares of AbbVie Inc. $ABBV - MarketBeat
Natixis Advisors LLC Sells 4,569 Shares of AbbVie Inc. $ABBV - MarketBeat
Korea Investment CORP Acquires 188,587 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Rhenman & Partners Asset Management AB - MarketBeat
Gabelli Funds LLC Decreases Stake in AbbVie Inc. $ABBV - MarketBeat
B. Metzler seel. Sohn & Co. AG Grows Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Stock Analysis: Performance, Financials, and OutlookNews and Statistics - IndexBox
Munich Reinsurance Co Stock Corp in Munich Invests $47.60 Million in AbbVie Inc. $ABBV - MarketBeat
Blair William & Co. IL Has $292.57 Million Position in AbbVie Inc. $ABBV - MarketBeat
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):